Search research articles
Contact Us
Filters
Showing results (21-30 of 94) with videos related to
Page
of 10
Sort By:
Frontiers in Aging Neuroscience
|
February 26, 2025
Improved early postoperative cognition in elderly gastrointestinal patients: a randomized controlled trial on the role of ultrasound-guided stellate ganglion block
Ruyue Xue, Yuexian Li, Mei Zhan, et al.
Plos One
|
April 29, 2020
Validating the Chinese geriatric trigger tool and analyzing adverse drug event associated risk factors in elderly Chinese patients: A retrospective review
Qiaozhi Hu, Zhou Qin, Mei Zhan, et al.
Journal of Evidence-Based Medicine
|
December 5, 2018
Adverse events identified by the global trigger tool at a university hospital: A retrospective medical record review
Qiaozhi Hu, Bin Wu, Mei Zhan, et al.
Nature Protocols
|
March 16, 2013
Microfluidic trap array for massively parallel imaging of Drosophila embryos
Thomas J Levario, Mei Zhan, Bomyi Lim, et al.
Materials (Basel, Switzerland)
|
November 9, 2018
Characterization and Analysis of Strain Heterogeneity at Grain-Scale of Titanium Alloy with Tri-Modal Microstructure during Tensile Deformation
Pengfei Gao, Yanxi Li, Ronghai Wu, et al.
International Journal of Clinical Pharmacy
|
June 30, 2019
Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method
Qiaozhi Hu, Zhou Qin, Mei Zhan, et al.
Plos One
|
October 3, 2013
Evaluation of bacterial expansin EXLX1 as a cellulase synergist for the saccharification of lignocellulosic Agro-industrial wastes
Hui Lin, Qi Shen, Ju-Mei Zhan, et al.
Cancer Management and Research
|
December 28, 2020
Cost-Effectiveness Analysis of Maintenance Olaparib in Patients with Metastatic Pancreatic Cancer and a Germline BRCA1/2 Mutation Based on the POLO Trial
Mei Zhan, Hanrui Zheng, Yu Yang, et al.
Journal of Medical Economics
|
December 21, 2019
Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with α-fetoprotein concentrations of at least 400 ng/ml
Hanrui Zheng, Zhou Qin, Xingjian Qiu, et al.
Frontiers in Public Health
|
July 17, 2023
Cost-effectiveness analysis of trastuzumab deruxtecan in patients with HER2-low advanced breast cancer based on DESTINY-Breast04
Mei Zhan, Zijia Huang, Ting Xu, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 94) with videos related to
Sort By:
Page
of 10
Frontiers in Aging Neuroscience
|
February 26, 2025
Improved early postoperative cognition in elderly gastrointestinal patients: a randomized controlled trial on the role of ultrasound-guided stellate ganglion block
Ruyue Xue, Yuexian Li, Mei Zhan, et al.
Plos One
|
April 29, 2020
Validating the Chinese geriatric trigger tool and analyzing adverse drug event associated risk factors in elderly Chinese patients: A retrospective review
Qiaozhi Hu, Zhou Qin, Mei Zhan, et al.
Journal of Evidence-Based Medicine
|
December 5, 2018
Adverse events identified by the global trigger tool at a university hospital: A retrospective medical record review
Qiaozhi Hu, Bin Wu, Mei Zhan, et al.
Nature Protocols
|
March 16, 2013
Microfluidic trap array for massively parallel imaging of Drosophila embryos
Thomas J Levario, Mei Zhan, Bomyi Lim, et al.
Materials (Basel, Switzerland)
|
November 9, 2018
Characterization and Analysis of Strain Heterogeneity at Grain-Scale of Titanium Alloy with Tri-Modal Microstructure during Tensile Deformation
Pengfei Gao, Yanxi Li, Ronghai Wu, et al.
International Journal of Clinical Pharmacy
|
June 30, 2019
Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method
Qiaozhi Hu, Zhou Qin, Mei Zhan, et al.
Plos One
|
October 3, 2013
Evaluation of bacterial expansin EXLX1 as a cellulase synergist for the saccharification of lignocellulosic Agro-industrial wastes
Hui Lin, Qi Shen, Ju-Mei Zhan, et al.
Cancer Management and Research
|
December 28, 2020
Cost-Effectiveness Analysis of Maintenance Olaparib in Patients with Metastatic Pancreatic Cancer and a Germline BRCA1/2 Mutation Based on the POLO Trial
Mei Zhan, Hanrui Zheng, Yu Yang, et al.
Journal of Medical Economics
|
December 21, 2019
Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with α-fetoprotein concentrations of at least 400 ng/ml
Hanrui Zheng, Zhou Qin, Xingjian Qiu, et al.
Frontiers in Public Health
|
July 17, 2023
Cost-effectiveness analysis of trastuzumab deruxtecan in patients with HER2-low advanced breast cancer based on DESTINY-Breast04
Mei Zhan, Zijia Huang, Ting Xu, et al.
Page
of 10